Tanaka M, Zhang Y X, Ishida H, Akasaka T, Sato K, Hayakawa I
Exploratory Research Laboratories 1, Daiichi Pharmaceutical Co. Ltd, Tokyo, Japan.
J Med Microbiol. 1995 Mar;42(3):214-9. doi: 10.1099/00222615-42-3-214.
Ninety-two and 33 methicillin-resistant Staphylococcus aureus (MRSA) strains were isolated in Japan and China respectively. They were categorised as ofloxacin-susceptible (MIC < 12.5 mg/L), moderately (MIC 12.5-25 mg/L) or highly (MIC > or = 50 mg/L) ofloxacin-resistant. 4-Quinolone concentrations required to inhibit purified DNA gyrase from the moderately and highly quinolone-resistant MRSA were at least 20 times higher than those required to inhibit the equivalent enzyme from quinolone-susceptible strains. Reconstitution assays demonstrated that the 4-quinolone-resistant MRSA had a mutation in subunit A of DNA gyrase. A portion of the gyrA gene from amino acids codons 40-115 was sequenced. Four moderately resistant and seven highly resistant MRSA contained a Ser-->Leu substitution at amino acid 84; one moderately and one highly resistant MRSA and one moderately resistant methicillin-susceptible S. aureus (MSSA) strain contained a Glu-->Lys substitution at amino acid 88. Eight MRSA, including one quinolone-susceptible strain and one MSSA contained a silent mutation at amino acid 86. Uptake of ofloxacin in moderately resistant strains was almost the same in the presence or absence of carbonyl cyanide m-chlorophenylhydrazone (CCCP), whereas in highly resistant strains, uptake increased when CCCP was added. Restriction fragment length analysis of the norA gene with the restriction endonuclease SfcI showed a mutation of nucleotide position 1085 in all MRSA strains tested except for one highly quinolone-resistant strain. Thus the mechanisms of 4-quinolone-resistance in these MRSA isolates involved alterations in both DNA gyrase and antimicrobial uptake and efflux.
在日本和中国分别分离出92株和33株耐甲氧西林金黄色葡萄球菌(MRSA)。它们被分类为对氧氟沙星敏感(MIC<12.5mg/L)、中度(MIC 12.5 - 25mg/L)或高度(MIC≥50mg/L)耐氧氟沙星。抑制中度和高度喹诺酮耐药MRSA的纯化DNA促旋酶所需的4 - 喹诺酮浓度比抑制喹诺酮敏感菌株的等效酶所需浓度至少高20倍。重组试验表明,耐4 - 喹诺酮的MRSA在DNA促旋酶A亚基中有一个突变。对gyrA基因从氨基酸密码子40 - 115的部分进行了测序。4株中度耐药和7株高度耐药的MRSA在氨基酸84处有Ser→Leu替换;1株中度耐药、1株高度耐药的MRSA和1株中度耐药的甲氧西林敏感金黄色葡萄球菌(MSSA)菌株在氨基酸88处有Glu→Lys替换。8株MRSA,包括1株喹诺酮敏感菌株和1株MSSA在氨基酸86处有一个沉默突变。在中度耐药菌株中,无论有无羰基氰化物间氯苯腙(CCCP),氧氟沙星的摄取几乎相同,而在高度耐药菌株中,添加CCCP时摄取增加。用限制性内切酶SfcI对norA基因进行限制性片段长度分析表明,除1株高度喹诺酮耐药菌株外,所有测试的MRSA菌株中核苷酸位置1085都有突变。因此,这些MRSA分离株中4 - 喹诺酮耐药的机制涉及DNA促旋酶以及抗菌药物摄取和外排的改变。